PRKCD and systemic lupus erythematosus: In addition, the inhibition of PKCδ, which is a step in the ERK pathway (PKC-ras-raf-MEK-ERK), causes hypomethylation of the CD70 promoter and enhances CD70 expression, resembling that seen in lupus or 5-aza-cytidine treated T cells [46,47].